Pre-miR-21 Conformational Equilibrium Modulates the Efficacy of the Maturation Inhibitor L50

Area of Science:

• Biochemistry
• Molecular Biology
• RNA Therapeutics

Background:

• The cyclic peptide L50 is a potential anticancer drug targeting pre-miR-21 maturation.
• Pre-miR-21 exists in an equilibrium between a Bulged and a Paired state, affecting Dicer susceptibility.
• The impact of this equilibrium on L50's efficacy is not well understood.

Purpose of the Study:

• To investigate the effect of pre-miR-21 conformational equilibrium on L50's anticancer activity.
• To elucidate the molecular mechanisms underlying L50's efficacy under different pH conditions.

Main Methods:

• Biochemical assays to measure L50 activity and affinity.
• Structural analyses to determine binding modes.
• pH-dependent studies to mimic conformational changes.

Main Results:

• L50 showed reduced inhibitory activity and binding affinity for the Paired state of pre-miR-21.
• Altered binding modes and loss of key interactions were observed in the Paired state.
• pH variations influenced L50's interaction with pre-miR-21.

Conclusions:

• The conformational equilibrium of pre-miR-21 significantly impacts L50 efficacy.
• L50's reduced efficacy in the Paired state is due to weakened binding interactions.
• Considering RNA conformational dynamics is essential for optimizing RNA-targeting drug development.